1. Platelet Surface CD62p and Serum Vitamin D Levels are Associated with Clopidogrel Resistance in Chinese Patients with Ischemic Stroke
   Bi-Chao Lu et al, 2019, Journal of Stroke and Cerebrovascular Diseases CrossRef
2. The Phenomenon of Clopidogrel High On-Treatment Platelet Reactivity in Ischemic Stroke Subjects: A Comprehensive Review
   Adam Wiśniewski et al, 2020, International Journal of Molecular Sciences CrossRef
3. Associations of CYP3A4, NR1I2, CYP2C19 and P2RY12 polymorphisms with clopidogrel resistance in Chinese patients with ischemic stroke
   Rui Liu et al, 2016, Acta Pharmacologica Sinica CrossRef
4. Association Between ABCB1 Polymorphisms and Outcomes of Clopidogrel Treatment in Patients With Minor Stroke or Transient Ischemic Attack
   Yuesong Pan et al, 2019, JAMA Neurology CrossRef
5. Impact of Diabetes on Platelet Function in Acute Ischemic Stroke Patients Taking Dual Antiplatelet Therapy
   Yinping Guo et al, 2021, Frontiers in Neurology CrossRef
6. Meta-analysis of effects of ABCB1 polymorphisms on clopidogrel response among patients with coronary artery disease
   Yajing Zhai et al, 2017, European Journal of Clinical Pharmacology CrossRef
7. Investigating the Effect of Demographics, Clinical Characteristics, and Polymorphism of MDR-1, CYP1A2, CYP3A4, and CYP3A5 on Clopidogrel Resistance
   Belal A. Al-Husein et al, 2018, Journal of Cardiovascular Pharmacology CrossRef
8. High on-clopidogrel platelet reactivity in ischaemic stroke or transient ischaemic attack: Systematic review and meta-analysis
   Vafa Alakbarzade et al, 2020, Journal of Stroke and Cerebrovascular Diseases CrossRef
9. A Systematic Review of Clopidogrel Resistance in Vascular Surgery: Current Perspectives and Future Directions
   Young Kim et al, 2023, Annals of Vascular Surgery CrossRef
10. Genomewide Association Study Identifies Novel Genetic Loci That Modify Antiplatelet Effects and Pharmacokinetics of Clopidogrel
    W‐P Zhong et al, 2017, Clinical Pharmacology & Therapeutics CrossRef